ID   PARP9_HUMAN             Reviewed;         854 AA.
AC   Q8IXQ6; A8KA94; B2R8S9; E9PFM7; Q8TCP3; Q9BZL8; Q9BZL9;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2003, sequence version 2.
DT   10-MAY-2017, entry version 122.
DE   RecName: Full=Poly [ADP-ribose] polymerase 9;
DE            Short=PARP-9;
DE            EC=2.4.2.30;
DE   AltName: Full=ADP-ribosyltransferase diphtheria toxin-like 9;
DE            Short=ARTD9;
DE   AltName: Full=B aggressive lymphoma protein;
GN   Name=PARP9; Synonyms=BAL, BAL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, VARIANT CYS-528, AND INVOLVEMENT IN B-CELL
RP   LYMPHOMAS.
RC   TISSUE=B-cell;
RX   PubMed=11110709;
RA   Aguiar R.C.T., Yakushijin Y., Kharbanda S., Salgia R., Fletcher J.A.,
RA   Shipp M.A.;
RT   "BAL is a novel risk-related gene in diffuse large B-cell lymphomas
RT   that enhances cellular migration.";
RL   Blood 96:4328-4334(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   CYS-528.
RC   TISSUE=Trachea, and Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND
RP   VARIANTS VAL-517 AND CYS-528.
RC   TISSUE=Mammary gland, and Melanoma;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 525-854.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   INTERACTION WITH DTX3L.
RX   PubMed=12670957; DOI=10.1074/jbc.M301157200;
RA   Takeyama K., Aguiar R.C.T., Gu L., He C., Freeman G.J., Kutok J.L.,
RA   Aster J.C., Shipp M.A.;
RT   "The BAL-binding protein BBAP and related Deltex family members
RT   exhibit ubiquitin-protein isopeptide ligase activity.";
RL   J. Biol. Chem. 278:21930-21937(2003).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=16809771; DOI=10.1128/MCB.02351-05;
RA   Juszczynski P., Kutok J.L., Li C., Mitra J., Aguiar R.C.T.,
RA   Shipp M.A.;
RT   "BAL1 and BBAP are regulated by a gamma interferon-responsive
RT   bidirectional promoter and are overexpressed in diffuse large B-cell
RT   lymphomas with a prominent inflammatory infiltrate.";
RL   Mol. Cell. Biol. 26:5348-5359(2006).
RN   [8]
RP   NOMENCLATURE.
RX   PubMed=20106667; DOI=10.1016/j.tibs.2009.12.003;
RA   Hottiger M.O., Hassa P.O., Luscher B., Schuler H., Koch-Nolte F.;
RT   "Toward a unified nomenclature for mammalian ADP-
RT   ribosyltransferases.";
RL   Trends Biochem. Sci. 35:208-219(2010).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH PARP1, AND DOMAIN
RP   MACRO 2.
RX   PubMed=23230272; DOI=10.1128/MCB.00990-12;
RA   Yan Q., Xu R., Zhu L., Cheng X., Wang Z., Manis J., Shipp M.A.;
RT   "BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose)
RT   activation, ubiquitylation, and double-strand DNA repair independent
RT   of ATM, MDC1, and RNF8.";
RL   Mol. Cell. Biol. 33:845-857(2013).
CC   -!- FUNCTION: In concert with DTX3L plays a role in PARP1-dependent
CC       DNA damage repair. PARP1-dependent PARP9/BAL1-DTX3L-mediated
CC       ubiquitination promotes the rapid and specific recruitment of
CC       53BP1/TP53BP1, UIMC1/RAP80, and BRCA1 to DNA damage sites.
CC       Involved in inducing the expression of IFN-gamma-responsive genes.
CC       {ECO:0000269|PubMed:16809771, ECO:0000269|PubMed:23230272}.
CC   -!- CATALYTIC ACTIVITY: NAD(+) + (ADP-D-ribosyl)(n)-acceptor =
CC       nicotinamide + (ADP-D-ribosyl)(n+1)-acceptor.
CC       {ECO:0000255|PROSITE-ProRule:PRU00397}.
CC   -!- SUBUNIT: Interacts with DTX3L. Interacts with PARP1 (when poly-
CC       ADP-ribosylated). {ECO:0000269|PubMed:12670957,
CC       ECO:0000269|PubMed:23230272}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Nucleus. Note=Shuttles
CC       between the nucleus and the cytosol. Export to the cytosol depends
CC       on the interaction with DTX3L. Localizes at sites of DNA damage in
CC       a PARP1-dependent manner.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Long, L;
CC         IsoId=Q8IXQ6-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short, S;
CC         IsoId=Q8IXQ6-2; Sequence=VSP_008505;
CC       Name=3;
CC         IsoId=Q8IXQ6-3; Sequence=VSP_008505, VSP_046086, VSP_046087;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in lymphocyte-rich tissues, spleen,
CC       lymph nodes, peripheral blood lymphocytes and colonic mucosa. Also
CC       expressed in nonhematopoietic tissues such as heart and skeletal
CC       muscle. Isoform 2 is the predominant form. Most abundantly
CC       expressed in lymphomas with a brisk host inflammatory response. In
CC       diffuse large B-cell lymphomas tumors, expressed specifically by
CC       malignant B-cells. {ECO:0000269|PubMed:11110709,
CC       ECO:0000269|PubMed:16809771}.
CC   -!- INDUCTION: Up-regulated by IFN-gamma in B-cell lymphoma cell
CC       lines. {ECO:0000269|PubMed:16809771}.
CC   -!- DOMAIN: The domain macro 2 is required for recruitment to DNA
CC       damage sites. {ECO:0000269|PubMed:23230272}.
CC   -!- DISEASE: Note=Overexpressed at significantly higher levels in
CC       fatal high-risk diffuse large B-cell lymphomas (DLB-CL) compared
CC       to cured low-risk tumors. Overexpression in B-cell lymphoma
CC       transfectants may promote malignant B-cell migration. May
CC       therefore be involved in promoting B-cell migration and
CC       dissemination of high-risk DLB-CL tumors (PubMed:11110709).
CC       {ECO:0000269|PubMed:11110709}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF307338; AAK07558.1; -; mRNA.
DR   EMBL; AF307339; AAK07559.1; -; mRNA.
DR   EMBL; AK292959; BAF85648.1; -; mRNA.
DR   EMBL; AK313494; BAG36276.1; -; mRNA.
DR   EMBL; AC092908; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC096861; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017463; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; BC039580; AAH39580.1; -; mRNA.
DR   EMBL; AL713679; CAD28483.1; -; mRNA.
DR   CCDS; CCDS3014.1; -. [Q8IXQ6-1]
DR   CCDS; CCDS54633.1; -. [Q8IXQ6-3]
DR   CCDS; CCDS54634.1; -. [Q8IXQ6-2]
DR   RefSeq; NP_001139574.1; NM_001146102.1. [Q8IXQ6-1]
DR   RefSeq; NP_001139575.1; NM_001146103.1. [Q8IXQ6-2]
DR   RefSeq; NP_001139576.1; NM_001146104.1. [Q8IXQ6-2]
DR   RefSeq; NP_001139577.1; NM_001146105.1. [Q8IXQ6-2]
DR   RefSeq; NP_113646.2; NM_031458.2. [Q8IXQ6-1]
DR   RefSeq; XP_005247877.1; XM_005247820.2. [Q8IXQ6-1]
DR   RefSeq; XP_016862793.1; XM_017007304.1. [Q8IXQ6-1]
DR   RefSeq; XP_016862794.1; XM_017007305.1. [Q8IXQ6-2]
DR   RefSeq; XP_016862795.1; XM_017007306.1. [Q8IXQ6-2]
DR   UniGene; Hs.518200; -.
DR   PDB; 5AIL; X-ray; 1.55 A; A/B=310-493.
DR   PDBsum; 5AIL; -.
DR   ProteinModelPortal; Q8IXQ6; -.
DR   SMR; Q8IXQ6; -.
DR   BioGrid; 123723; 10.
DR   IntAct; Q8IXQ6; 1.
DR   STRING; 9606.ENSP00000353512; -.
DR   iPTMnet; Q8IXQ6; -.
DR   PhosphoSitePlus; Q8IXQ6; -.
DR   BioMuta; PARP9; -.
DR   DMDM; 48474734; -.
DR   EPD; Q8IXQ6; -.
DR   MaxQB; Q8IXQ6; -.
DR   PaxDb; Q8IXQ6; -.
DR   PeptideAtlas; Q8IXQ6; -.
DR   PRIDE; Q8IXQ6; -.
DR   Ensembl; ENST00000360356; ENSP00000353512; ENSG00000138496. [Q8IXQ6-1]
DR   Ensembl; ENST00000462315; ENSP00000418894; ENSG00000138496. [Q8IXQ6-3]
DR   Ensembl; ENST00000471785; ENSP00000419001; ENSG00000138496. [Q8IXQ6-2]
DR   Ensembl; ENST00000477522; ENSP00000419506; ENSG00000138496. [Q8IXQ6-2]
DR   GeneID; 83666; -.
DR   KEGG; hsa:83666; -.
DR   UCSC; uc003efh.5; human. [Q8IXQ6-1]
DR   CTD; 83666; -.
DR   DisGeNET; 83666; -.
DR   GeneCards; PARP9; -.
DR   HGNC; HGNC:24118; PARP9.
DR   HPA; HPA066708; -.
DR   MIM; 612065; gene.
DR   neXtProt; NX_Q8IXQ6; -.
DR   OpenTargets; ENSG00000138496; -.
DR   PharmGKB; PA134870403; -.
DR   eggNOG; KOG2633; Eukaryota.
DR   eggNOG; COG2110; LUCA.
DR   GeneTree; ENSGT00760000119084; -.
DR   HOGENOM; HOG000115452; -.
DR   HOVERGEN; HBG045406; -.
DR   InParanoid; Q8IXQ6; -.
DR   KO; K15260; -.
DR   OMA; SGIFQFP; -.
DR   OrthoDB; EOG091G02AK; -.
DR   PhylomeDB; Q8IXQ6; -.
DR   TreeFam; TF328965; -.
DR   Reactome; R-HSA-197264; Nicotinamide salvaging.
DR   GenomeRNAi; 83666; -.
DR   PRO; PR:Q8IXQ6; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000138496; -.
DR   CleanEx; HS_PARP9; -.
DR   ExpressionAtlas; Q8IXQ6; baseline and differential.
DR   Genevisible; Q8IXQ6; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0016477; P:cell migration; TAS:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; IMP:UniProtKB.
DR   GO; GO:0034356; P:NAD biosynthesis via nicotinamide riboside salvage pathway; TAS:Reactome.
DR   GO; GO:0060330; P:regulation of response to interferon-gamma; IDA:UniProtKB.
DR   InterPro; IPR002589; Macro_dom.
DR   InterPro; IPR034400; PARP9.
DR   InterPro; IPR012317; Poly(ADP-ribose)pol_cat_dom.
DR   PANTHER; PTHR14453:SF72; PTHR14453:SF72; 1.
DR   Pfam; PF01661; Macro; 2.
DR   SMART; SM00506; A1pp; 2.
DR   PROSITE; PS51154; MACRO; 2.
DR   PROSITE; PS51059; PARP_CATALYTIC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   DNA damage; DNA repair; NAD; Nucleus; Polymorphism;
KW   Reference proteome; Repeat; Transferase.
FT   CHAIN         1    854       Poly [ADP-ribose] polymerase 9.
FT                                /FTId=PRO_0000211339.
FT   DOMAIN      107    296       Macro 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00490}.
FT   DOMAIN      306    487       Macro 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00490}.
FT   DOMAIN      628    850       PARP catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00397}.
FT   VAR_SEQ      17     51       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:11110709,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008505.
FT   VAR_SEQ     729    745       DPKYGAGIYFTKNLKNL -> GRCQCLIIGATLWNLVS
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046086.
FT   VAR_SEQ     746    854       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046087.
FT   VARIANT      21     21       S -> L (in dbSNP:rs34006803).
FT                                /FTId=VAR_056654.
FT   VARIANT     517    517       I -> V (in dbSNP:rs28365795).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_056655.
FT   VARIANT     528    528       Y -> C (in dbSNP:rs9851180).
FT                                {ECO:0000269|PubMed:11110709,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_056656.
FT   VARIANT     651    651       T -> A (in dbSNP:rs6780543).
FT                                /FTId=VAR_056657.
FT   CONFLICT    487    487       S -> P (in Ref. 2; BAF85648).
FT                                {ECO:0000305}.
FT   CONFLICT    839    839       F -> S (in Ref. 2; BAG36276).
FT                                {ECO:0000305}.
FT   STRAND      311    314       {ECO:0000244|PDB:5AIL}.
FT   STRAND      317    324       {ECO:0000244|PDB:5AIL}.
FT   HELIX       326    328       {ECO:0000244|PDB:5AIL}.
FT   STRAND      330    339       {ECO:0000244|PDB:5AIL}.
FT   HELIX       347    356       {ECO:0000244|PDB:5AIL}.
FT   HELIX       358    370       {ECO:0000244|PDB:5AIL}.
FT   STRAND      378    382       {ECO:0000244|PDB:5AIL}.
FT   STRAND      386    395       {ECO:0000244|PDB:5AIL}.
FT   HELIX       402    419       {ECO:0000244|PDB:5AIL}.
FT   STRAND      423    427       {ECO:0000244|PDB:5AIL}.
FT   STRAND      433    437       {ECO:0000244|PDB:5AIL}.
FT   HELIX       439    456       {ECO:0000244|PDB:5AIL}.
FT   STRAND      462    468       {ECO:0000244|PDB:5AIL}.
FT   HELIX       473    490       {ECO:0000244|PDB:5AIL}.
SQ   SEQUENCE   854 AA;  96343 MW;  CBBB3B4B7CA1CDA4 CRC64;
     MDFSMVAGAA AYNEKSGRIT SLSLLFQKVF AQIFPQWRKG NTEECLPYKC SETGALGENY
     SWQIPINHND FKILKNNERQ LCEVLQNKFG CISTLVSPVQ EGNSKSLQVF RKMLTPRIEL
     SVWKDDLTTH AVDAVVNAAN EDLLHGGGLA LALVKAGGFE IQEESKQFVA RYGKVSAGEI
     AVTGAGRLPC KQIIHAVGPR WMEWDKQGCT GKLQRAIVSI LNYVIYKNTH IKTVAIPALS
     SGIFQFPLNL CTKTIVETIR VSLQGKPMMS NLKEIHLVSN EDPTVAAFKA ASEFILGKSE
     LGQETTPSFN AMVVNNLTLQ IVQGHIEWQT ADVIVNSVNP HDITVGPVAK SILQQAGVEM
     KSEFLATKAK QFQRSQLVLV TKGFNLFCKY IYHVLWHSEF PKPQILKHAM KECLEKCIEQ
     NITSISFPAL GTGNMEIKKE TAAEILFDEV LTFAKDHVKH QLTVKFVIFP TDLEIYKAFS
     SEMAKRSKML SLNNYSVPQS TREEKRENGL EARSPAINLM GFNVEEMYEA HAWIQRILSL
     QNHHIIENNH ILYLGRKEHD ILSQLQKTSS VSITEIISPG RTELEIEGAR ADLIEVVMNI
     EDMLCKVQEE MARKKERGLW RSLGQWTIQQ QKTQDEMKEN IIFLKCPVPP TQELLDQKKQ
     FEKCGLQVLK VEKIDNEVLM AAFQRKKKMM EEKLHRQPVS HRLFQQVPYQ FCNVVCRVGF
     QRMYSTPCDP KYGAGIYFTK NLKNLAEKAK KISAADKLIY VFEAEVLTGF FCQGHPLNIV
     PPPLSPGAID GHDSVVDNVS SPETFVIFSG MQAIPQYLWT CTQEYVQSQD YSSGPMRPFA
     QHPWRGFASG SPVD
//
